NSBNEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 13 Aug 2026, 18:22 | Pre-IND Meeting with US FDA Scheduled | Company Update | — | 11001 | |
| 28 July 2026, 20:02 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 21 July 2026, 21:08 | StemSmart Presentation - ISCT ANZ 2026 | Presentations | — | 03026 | |
| 1 July 2026, 19:56 | Notification of cessation of securities - NSB | Other | — | 06027 | |
| 19 June 2026, 23:12 | Escrowed Securities Update | Securities Administration | — | 06009 | |
| 11 June 2026, 22:50 | Investor Webinar | Presentations | — | 14014 | |
| 9 June 2026, 18:21 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 4 June 2026, 03:26 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 3 June 2026, 03:41 | Change of Director's Interest Notice x2 | Director Interests | — | 02009 | |
| 2 June 2026, 03:35 | Section 708A Notice | Securities Administration | — | 06018 | |
| 2 June 2026, 03:30 | Application for quotation of securities - NSB | Other | — | 06020 | |
| 26 May 2026, 22:17 | Updated Presentation - Successful Results | Presentations | — | 03026 | |
| 26 May 2026, 19:30 | Remarkable Results from Patients treated with StemSmart | Company Update | MS | 09014, 11001 | |
| 25 May 2026, 19:44 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 30 Apr 2026, 18:46 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 17 Mar 2026, 20:38 | StemSmart Manufacturing Scale-Up Transfer Advances | Company Update | — | 11001 | |
| 26 Feb 2026, 06:00 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 16 Feb 2026, 20:53 | Company Presentation | Presentations | — | 03026 | |
| 30 Jan 2026, 19:27 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 13 Jan 2026, 20:51 | Successful Clinical Results Achieved under Special Access | Company Update | MS | 09014, 11001 | |
| 9 Jan 2026, 20:27 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 13 Nov 2025, 02:06 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 12 Nov 2025, 21:00 | Investor Webinar Update | Company Administration | — | 12008 | |
| 11 Nov 2025, 20:26 | Fourth Patient Commences StemSmart MSC Treatment | Company Update | MS | 11001 | |
| 6 Nov 2025, 20:28 | Clinical & Scientific Advisory Board Appointed | Company Administration | — | 12008 | |
| 30 Oct 2025, 20:10 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 21 Oct 2025, 20:23 | AusBiotech Presentation | Presentations | — | 03026 | |
| 7 Oct 2025, 20:27 | First Patients Approved for Special Access Program | Company Update | — | 11001 | |
| 2 Oct 2025, 20:15 | Letter to Shareholders & Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 2 Oct 2025, 20:15 | Notice of Meeting & Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 19 Sept 2025, 18:56 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 16 Sept 2025, 19:46 | Date of AGM & Closing Date for Director Nominations | Meetings & Governance | — | 08006, 12008 | |
| 16 Sept 2025, 19:28 | Notification regarding unquoted securities - NSB | Other | — | 06021 | |
| 29 Aug 2025, 03:23 | Appendix 4G & Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 29 Aug 2025, 03:23 | 2025 Annual Report & Appendix 4E | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 27 Aug 2025, 19:49 | Previous StemSmart Studies Support Renal Transplantation | Company Update | MS | 11001 | |
| 19 Aug 2025, 18:47 | Presentation - TechKnow Invest Roadshow Conference | Presentations | — | 03026 |
1–37 of 37
1 / 1